nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—Procainamide—Sunitinib—pancreatic cancer	0.463	1	CrCrCtD
Lucanthone—TOP1—Irinotecan—pancreatic cancer	0.341	0.713	CbGbCtD
Lucanthone—TOP2A—Epirubicin—pancreatic cancer	0.0896	0.187	CbGbCtD
Lucanthone—TOP2A—Doxorubicin—pancreatic cancer	0.0476	0.0996	CbGbCtD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNFRSF10B—pancreatic cancer	0.00225	0.0455	CbGpPWpGaD
Lucanthone—APEX1—Homologous Recombination Repair—BRCA2—pancreatic cancer	0.0021	0.0425	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RAP1GAP—pancreatic cancer	0.0021	0.0424	CbGpPWpGaD
Lucanthone—APEX1—Double-Strand Break Repair—BRCA2—pancreatic cancer	0.00165	0.0334	CbGpPWpGaD
Lucanthone—APEX1—islet of Langerhans—pancreatic cancer	0.00162	0.286	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNFSF10—pancreatic cancer	0.0015	0.0304	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.00149	0.0301	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—PALB2—pancreatic cancer	0.00125	0.0252	CbGpPWpGaD
Lucanthone—APEX1—pancreas—pancreatic cancer	0.00114	0.201	CbGeAlD
Lucanthone—APEX1—Extension of Telomeres—TERT—pancreatic cancer	0.00114	0.023	CbGpPWpGaD
Lucanthone—TOP1—islet of Langerhans—pancreatic cancer	0.00114	0.2	CbGeAlD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.00108	0.0219	CbGpPWpGaD
Lucanthone—APEX1—digestive system—pancreatic cancer	0.000975	0.172	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—BCL2L1—pancreatic cancer	0.00094	0.019	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—KDR—pancreatic cancer	0.000915	0.0185	CbGpPWpGaD
Lucanthone—TOP1—pancreas—pancreatic cancer	0.000799	0.141	CbGeAlD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000762	0.0154	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—AHR—pancreatic cancer	0.000751	0.0152	CbGpPWpGaD
Lucanthone—APEX1—Doxorubicin—Epirubicin—pancreatic cancer	0.000731	0.209	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000684	0.0138	CbGpPWpGaD
Lucanthone—APEX1—Epirubicin—Doxorubicin—pancreatic cancer	0.000676	0.193	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle—SYCP1—pancreatic cancer	0.000676	0.0137	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000675	0.0137	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.00059	0.0119	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—CASP3—pancreatic cancer	0.000582	0.0118	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.00058	0.0117	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—GADD45A—pancreatic cancer	0.000576	0.0116	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EZH2—pancreatic cancer	0.000567	0.0115	CbGpPWpGaD
Lucanthone—APEX1—Telomere Maintenance—TERT—pancreatic cancer	0.000515	0.0104	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—VEGFA—pancreatic cancer	0.000504	0.0102	CbGpPWpGaD
Lucanthone—TOP2A—Topotecan—Irinotecan—pancreatic cancer	0.000502	0.143	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000497	0.01	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000465	0.00941	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—BRCA2—pancreatic cancer	0.000462	0.00934	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RB1—pancreatic cancer	0.000458	0.00926	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—NOTCH1—pancreatic cancer	0.000453	0.00915	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000449	0.00908	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000435	0.0088	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—pancreatic cancer	0.000431	0.00871	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—TERT—pancreatic cancer	0.000429	0.00867	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000427	0.00864	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNF—pancreatic cancer	0.000423	0.00855	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TYMS—pancreatic cancer	0.00041	0.00829	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—pancreatic cancer	0.000408	0.00824	CbGpPWpGaD
Lucanthone—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	0.000353	0.101	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle—RBBP8—pancreatic cancer	0.000346	0.00699	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—RB1—pancreatic cancer	0.000339	0.00686	CbGpPWpGaD
Lucanthone—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	0.000338	0.0966	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000338	0.00683	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000324	0.00655	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—RB1—pancreatic cancer	0.000318	0.00644	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—AKT1—pancreatic cancer	0.000315	0.00637	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—SYCP1—pancreatic cancer	0.000313	0.00632	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.00031	0.00627	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—pancreatic cancer	0.000308	0.00622	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—SRC—pancreatic cancer	0.000304	0.00615	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.000301	0.00608	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—STAT3—pancreatic cancer	0.000294	0.00594	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PPARG—pancreatic cancer	0.000291	0.00588	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—RB1—pancreatic cancer	0.000288	0.00582	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—CTNNB1—pancreatic cancer	0.000285	0.00576	CbGpPWpGaD
Lucanthone—APEX1—S Phase—RB1—pancreatic cancer	0.000278	0.00563	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MYC—pancreatic cancer	0.000273	0.00552	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PPP2R5B—pancreatic cancer	0.000269	0.00544	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	0.000268	0.00542	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.00025	0.00506	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—pancreatic cancer	0.000244	0.00494	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—FOXM1—pancreatic cancer	0.00024	0.00485	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000238	0.00481	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000238	0.00481	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—pancreatic cancer	0.000237	0.00478	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—AHR—pancreatic cancer	0.000235	0.00474	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—PIK3CA—pancreatic cancer	0.000232	0.00468	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—pancreatic cancer	0.000231	0.00467	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL8—pancreatic cancer	0.000229	0.00464	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—pancreatic cancer	0.000226	0.00457	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000221	0.00447	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CASP3—pancreatic cancer	0.00022	0.00444	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000215	0.00435	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—HRAS—pancreatic cancer	0.000214	0.00433	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCND1—pancreatic cancer	0.000214	0.00432	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000214	0.00432	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000213	0.00431	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000211	0.00426	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000208	0.0042	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MMP9—pancreatic cancer	0.000207	0.00419	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCND1—pancreatic cancer	0.000207	0.00418	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PTEN—pancreatic cancer	0.000199	0.00403	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000193	0.00389	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—pancreatic cancer	0.00019	0.00383	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—pancreatic cancer	0.000189	0.00382	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000188	0.00379	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000184	0.00373	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000181	0.00366	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EZH2—pancreatic cancer	0.000177	0.00358	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—TYMS—pancreatic cancer	0.000176	0.00356	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000173	0.00349	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000172	0.00348	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—pancreatic cancer	0.000171	0.00346	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TGFB1—pancreatic cancer	0.000171	0.00346	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.00017	0.00343	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000169	0.00341	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—pancreatic cancer	0.000168	0.00339	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—pancreatic cancer	0.000166	0.00335	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000161	0.00325	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RBBP8—pancreatic cancer	0.00016	0.00323	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TNF—pancreatic cancer	0.00016	0.00323	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.00016	0.00322	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000155	0.00314	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000147	0.00296	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000142	0.00287	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—pancreatic cancer	0.000141	0.00285	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.00014	0.00284	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TYMS—pancreatic cancer	0.00014	0.00283	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.000139	0.00281	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—pancreatic cancer	0.000136	0.00275	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000136	0.00275	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000134	0.0027	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BRCA2—pancreatic cancer	0.000131	0.00266	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TYMS—pancreatic cancer	0.000128	0.00259	CbGpPWpGaD
Lucanthone—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	0.000127	0.0364	CbGdCrCtD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	0.000126	0.00255	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TYMS—pancreatic cancer	0.000125	0.00253	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PPP2R5B—pancreatic cancer	0.000124	0.00252	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	0.000124	0.00251	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.00012	0.00242	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RB1—pancreatic cancer	0.000119	0.00242	CbGpPWpGaD
Lucanthone—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	0.000118	0.0337	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Epirubicin—pancreatic cancer	0.000118	0.0337	CbGdCrCtD
Lucanthone—TOP2A—Idarubicin—Epirubicin—pancreatic cancer	0.000118	0.0337	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—FOXM1—pancreatic cancer	0.000111	0.00224	CbGpPWpGaD
Lucanthone—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	0.000109	0.0312	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Doxorubicin—pancreatic cancer	0.000109	0.0312	CbGdCrCtD
Lucanthone—TOP2A—Idarubicin—Doxorubicin—pancreatic cancer	0.000109	0.0312	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle—TERT—pancreatic cancer	0.000109	0.0022	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	0.000105	0.00212	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000101	0.00205	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	0.000101	0.00204	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	9.69e-05	0.00196	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RB1—pancreatic cancer	9.48e-05	0.00192	CbGpPWpGaD
Lucanthone—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	9.13e-05	0.0261	CbGdCrCtD
Lucanthone—TOP2A—Circadian rythm related genes—PPARG—pancreatic cancer	9.08e-05	0.00184	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	8.87e-05	0.00179	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RB1—pancreatic cancer	8.47e-05	0.00171	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	8.33e-05	0.00168	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	8.31e-05	0.00168	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2A—pancreatic cancer	7.45e-05	0.00151	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	7.44e-05	0.0015	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—pancreatic cancer	7.12e-05	0.00144	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND1—pancreatic cancer	7.04e-05	0.00142	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	6.91e-05	0.0014	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	6.72e-05	0.00136	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	6.66e-05	0.00135	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	6.49e-05	0.00131	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TYMS—pancreatic cancer	6.46e-05	0.00131	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND1—pancreatic cancer	6.29e-05	0.00127	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PTEN—pancreatic cancer	6.23e-05	0.00126	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BRCA2—pancreatic cancer	6.08e-05	0.00123	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	6.02e-05	0.00122	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	5.86e-05	0.00118	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TYMS—pancreatic cancer	5.78e-05	0.00117	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—pancreatic cancer	5.65e-05	0.00114	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	5.39e-05	0.00109	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	5.38e-05	0.00109	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	5.27e-05	0.00107	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—pancreatic cancer	5.05e-05	0.00102	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TERT—pancreatic cancer	5.04e-05	0.00102	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	5.02e-05	0.00102	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	4.98e-05	0.00101	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.58e-05	0.000925	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.43e-05	0.000895	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RB1—pancreatic cancer	4.38e-05	0.000886	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—pancreatic cancer	4.25e-05	0.000859	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—pancreatic cancer	4.15e-05	0.000838	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RB1—pancreatic cancer	3.92e-05	0.000792	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	3.85e-05	0.000779	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.74e-05	0.000756	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2A—pancreatic cancer	3.44e-05	0.000696	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND1—pancreatic cancer	3.25e-05	0.000658	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND1—pancreatic cancer	2.91e-05	0.000588	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—pancreatic cancer	2.61e-05	0.000528	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYC—pancreatic cancer	2.33e-05	0.000472	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—pancreatic cancer	1.92e-05	0.000388	CbGpPWpGaD
